Chemoinformaics analysis of 2-CHLOROACETALDEHYDE
| Molecular Weight | 78.498 | nRot | 1 |
| Heavy Atom Molecular Weight | 75.474 | nRig | 1 |
| Exact Molecular Weight | 77.9872 | nRing | 0 |
| Solubility: LogS | -6.508 | nHRing | 0 |
| Solubility: LogP | 6.768 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 7 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 4 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 3 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 8.32238 |
| nHD | 0 | BPOL | 4.38762 |
| QED | 0.32 |
| Synth | 1.83 |
| Natural Product Likeliness | 0.016 |
| NR-PPAR-gamma | 0.076 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.077 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.655 |
| MDCK | 0.000018 |
| BBB | 0.258 |
| PPB | 0.973463 |
| VDSS | 1.709 |
| FU | 0.020271 |
| CYP1A2-inh | 0.42 |
| CYP1A2-sub | 0.191 |
| CYP2c19-inh | 0.449 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.282 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.012 |
| CYP3a4-inh | 0.24 |
| CYP3a4-sub | 0.076 |
| CL | 5.603 |
| T12 | 0.337 |
| hERG | 0.063 |
| Ames | 0.004 |
| ROA | 0.023 |
| SkinSen | 0.948 |
| Carcinogencity | 0.084 |
| EI | 0.971 |
| Respiratory | 0.81 |
| NR-Aromatase | 0.029 |
| Antiviral | No |
| Prediction | 0.910667 |